Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules

Amanda Jane Leach, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter McIntyre, Heidi Smith-Vaugha, Sue A. Skull, Victor M. Oguoma, Mark D. Chatfield, Deborah Lehmann, Christopher G. Brennan-Jones, Michael J. Binks, Paul V. Licciardi, Ross M. Andrews, Tom Snelling, Vicki Krause, Jonathan CarapetisAnne B. Chang, Peter Stanley Morris

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science